Skip to main content
Premium Trial:

Request an Annual Quote

Roka Bioscience Targets $100M Public Offering With Shelf Registration

NEW YORK (GenomeWeb) – Food safety testing firm Roka Bioscience this week filed a shelf registration to publicly offer up to $100 million in its securities. 

The firm said in a document filed with the US Securities and Exchange Commission that it may offer from time to time its common stock, preferred stock, warrants, senior or subordinated debt securities, and units consisting of combinations of its securities. 

Proceeds from any offering will be directed toward general corporate purposes, including R&D, product manufacturing, acquisitions, and investments into the business, as well as working capital, the reduction of indebtedness, and capital expenditures. 

Roka develops molecular diagnostic technologies for detecting foodborne pathogens. The Warren, New Jersey-based company raised $60 million in gross proceeds in July 2014 from its initial public offering.